Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3

被引:12
|
作者
Djigoue, Guy Bertrand [1 ,2 ]
Kenmogne, Lucie Carolle [1 ,2 ]
Roy, Jenny [1 ]
Poirier, Donald [1 ,2 ]
机构
[1] CHU Qubec, Res Ctr CHUL T4, Med Chem Lab, Quebec City, PQ, Canada
[2] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada
基金
加拿大健康研究院;
关键词
Steroids; Spiromorpholinone; Synthesis; Enzyme inhibitor; 17 beta-Hydroxysteroid dehydrogenase; PROSTATE-CANCER; 3-BETA-SUBSTITUTED DERIVATIVES; DEHYDROGENASE;
D O I
10.1016/j.bmcl.2013.09.072
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Spiromorpholinone derivatives were synthesized from androsterone or cyclohexanone in 6 or 3 steps, respectively, and these scaffolds were used for the introduction of a hydrophobic group via a nucleophilic substitution. Non-steroidal spiromorpholinones are not active as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 3 (17 beta-HSD3), but steroidal morpholinones are very potent inhibitors. In fact, those with (S) stereochemistry are more active than their (R) homologues, whereas N-benzylated compounds are more active than their non substituted precursors. The target compounds exhibited strong inhibition of 17 beta-HSD3 in rat testis homogenate (87-92% inhibition at 1 mu M). (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6360 / 6362
页数:3
相关论文
共 50 条
  • [31] Synthesis and evaluation of thiadiazole derivatives as inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Pradaux-Caggiano, Fabienne
    Su, Xiangdong
    Vicker, Nigel
    Thomas, Mark P.
    Smithen, Deborah
    Halem, Heather A.
    Culler, Michael D.
    Potter, Barry V. L.
    MEDCHEMCOMM, 2012, 3 (09) : 1117 - 1124
  • [32] Testosterone Synthesis in Patients with 17β-Hydroxysteroid Dehydrogenase 3 Deficiency
    Werner, R.
    Kulle, A.
    Sommerfeld, I.
    Riepe, F. G.
    Wudy, S.
    Hartmann, M. F.
    Merz, H.
    Doehnert, U.
    Bertelloni, S.
    Holterhus, P. -M.
    Hiort, O.
    SEXUAL DEVELOPMENT, 2012, 6 (04) : 161 - 168
  • [33] Curcumin Derivatives Inhibit Testicular 17β-Hydroxysteroid Dehydrogenase 3.
    Hu, G. X.
    Liang, G.
    Chu, Y. H.
    Li, X. K.
    Lian, Q. Q.
    Lin, H.
    Huang, Y. D.
    Hardy, D. O.
    Ge, R. S.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [34] Androsterone derivatives substituted at position 16:: Chemical synthesis, inhibition of type 3 17β-hydroxysteroid dehydrogenase, binding affinity for steroid receptors and proliferative/antiproliferative activity on shionogi (AR+) cells
    Tchédam-Ngatcha, B
    Luu-The, V
    Poirier, D
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2002, 17 (03) : 155 - 165
  • [35] A- and D-Ring Structural Modifications of an Androsterone Derivative Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3: Chemical Synthesis and Structure-Activity Relationships
    Cortes-Benitez, Francisco
    Roy, Jenny
    Perreault, Martin
    Maltais, Rene
    Poirier, Donald
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (15) : 7070 - 7088
  • [36] Chemical Synthesis, Characterisation and Biological Evaluation of Furanic-Estradiol Derivatives as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
    Farhane, Siham
    Laplante, Yannick
    Poirier, Donald
    MEDICINAL CHEMISTRY, 2011, 7 (02) : 80 - 91
  • [37] Chemical synthesis, characterisation and biological evaluation of lactonic-estradiol derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Farhane, Siham
    Fournier, Michelle-Audrey
    Poirier, Donald
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 : 322 - 331
  • [38] Design and synthesis of bisubstrate inhibitors of type 1 17β-hydroxysteroid dehydrogenase: Overview and perspectives
    Fournier, D.
    Poirier, D.
    Mazumdar, M.
    Lin, S. -X.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (11) : 2298 - 2306
  • [39] Estrone and estradiol C-16 derivatives as inhibitors of type 1 17β-hydroxysteroid dehydrogenase
    Poirier, D
    Chang, H
    Azzi, A
    Boivin, RP
    Lin, SX
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 236 - 238
  • [40] Novel and potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors
    Lawrence, HR
    Vicker, N
    Allan, GM
    Smith, A
    Mahon, MF
    Tutill, HJ
    Purohit, A
    Reed, MJ
    Potter, BVL
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) : 2759 - 2762